NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,920 | -76.9% | 12,000 | -71.7% | 0.00% | – |
| Q2 2023 | $164,262 | -68.9% | 42,445 | -77.8% | 0.00% | – |
| Q1 2023 | $528,699 | +1133.2% | 190,866 | +701.4% | 0.00% | – |
| Q4 2022 | $42,872 | -45.7% | 23,818 | -35.9% | 0.00% | – |
| Q3 2022 | $79,000 | -76.3% | 37,170 | -70.1% | 0.00% | – |
| Q2 2022 | $334,000 | -63.5% | 124,217 | -41.1% | 0.00% | – |
| Q1 2022 | $914,000 | -59.3% | 210,895 | -51.4% | 0.00% | – |
| Q4 2021 | $2,248,000 | +50.1% | 433,704 | +77.8% | 0.00% | – |
| Q3 2021 | $1,498,000 | +189.7% | 243,945 | +376.1% | 0.00% | – |
| Q2 2021 | $517,000 | – | 51,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
| Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
| ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
| Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
| Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
| Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
| Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |